top of page
(僅限英語版本)
-
Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac): a retrospective cohort study
-
Adverse Events of Special Interest and mortality following the mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines
bottom of page